Alzheimer’s pathophysiology

Alzheimer’s ailment is a modern dementia with lack of neurons and the presence of two foremost microscopic neuropathological hallmarks: extracellular amyloid plaques and intracellular neurofibrillary tangles. Early onset AD, a rare familial shape, is prompted due to mutation of 1 out of 3 genes: (amyloid precursor protein), (presenilin 2) or (presenilin 1).  Sporadic shape takes place generally after age of 65 and bills for most instances; it maximum probable effects from a mixture of genetic and influence of surroundings. Confirmed hazard factors for sporadic AD are age and the presence of the E4 allele of (Apo lipoprotein E). Amyloid plaques contain specifically of the neurotoxic peptide amyloid (Aβ, Abeta), cleaved sequentially from a bigger precursor protein (APP) through two enzymes: β-secretase (also known as BACE1) and γ-secretase (comprising 4 proteins, presenilin is one in every of them). If APP is first cleaved by way of the enzyme α-secretase rather than β-secretase then Aβ isn't always fashioned. Neurofibrillary tangles contain especially of the protein tau which binds with microtubules, which facilitating the neuronal shipping system. Tau uncoupling from microtubules and aggregation into tangles inhibits transport and consequences in disassembly of microtubule. Phosphorylation of tau might have an crucial function on this. Selective vulnerability of neuronal structures which includes the cholinergic, serotonergic, and noradrenergic and glutamatergic systems form the premise of modern-day rational pharmacological remedy.

•              Stem cells and Cell death

•              Cellular signaling, kinases, phosphatases, calcium

•              Cerebral Amyloid Angiopathy

•              Tau Pathology of Alzheimers Disease

•              Pathogenesis of Alzheimers Disease

 

    Related Conference of Alzheimer’s pathophysiology

    July 23-24, 2025

    15th Global Alzheimers Summit

    Paris, France
    July 28-29, 2025

    35th World Congress on Neurology and Neuroscience

    Paris, France
    September 04-05, 2025

    10th Annual Neurologists and Neurosurgeons Meet

    Vancouver, Canada
    September 15-16, 2025

    39th European Neurology Congress

    Paris, France
    September 25-26, 2025

    28th International Conference on Viral Infections & Virology

    Aix-en-Provence, France
    September 25-26, 2025

    12th Annual congress on Stroke and Neurological Disorders

    Zurich, Switzerland
    October 17-18, 2025

    5th International Conference on Child Neurology

    London, UK
    October 20-21, 2025

    20th Annual Congress on Neuroscience

    Paris, France
    October 20-21, 2025

    7th World Brain Congress

    Osaka, Japan
    October 23-24, 2025

    8th Global Congress on Spine and Spinal Disorders

    London, UK
    October 27-28, 2025

    36th World Congress on Neurorehabilitation

    Vancouver, Canada
    October 29-30, 2025

    5th Annual Dementia Congress

    Amsterdam, Netherlands
    November 13-14, 2025

    32nd Cognitive Neuroscience Congress

    Bali, Indonesia
    November 24-25, 2025

    37th World Conference on Neurology

    Barcelona, Spain
    November 27-28, 2025

    13th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    December 01-02, 2025

    38th European Neurology Congress 2025

    Vancouver, Canada
    December 04-05, 2025

    17th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    May 18-19, 2026

    38th International conference on Mental Health and Psychiatry

    Aix-en-Provence, France
    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France

    Alzheimer’s pathophysiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in